New York, NY (NewYorkInjuryNews.com)–The U.S. Food and Drug Administration (FDA) www.fda.gov announced drug makers are now required to place a black box warning on all metoclopramide containing drugs like Reglan. Federal regulators must warn patients, healthcare professionals and medication consumers about the risk of serious injury in long-term or high-dose use of all metoclopramide containing […]